Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
NGM-313 in Metabolic Dysfunction Associated Steatohepatitis: NCT04583423 Clinical Landscape Report 2026
16 October 2026
NCT04583423 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and develo…
9 min read
Midazolam in Anemia, Sickle Cell: NCT04586985 Clinical Landscape Report 2026
16 October 2026
NCT04586985 clinical landscape for Anemia, Sickle Cell: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Mirabegron in Myasthenia Gravis: TCTR20201019002 Clinical Landscape Report 2026
16 October 2026
TCTR20201019002 clinical landscape for Myasthenia Gravis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
TD-1058 in Idiopathic Pulmonary Fibrosis: NCT04589260 Clinical Landscape Report 2026
16 October 2026
NCT04589260 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Stem cell therapeutics (ExCellThera) in Hematologic Neoplasms: NCT04594031 Clinical Landscape Report 2026
16 October 2026
NCT04594031 clinical landscape for Hematologic Neoplasms: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Zinpentraxin alfa in Idiopathic Pulmonary Fibrosis: NCT04594707 Clinical Landscape Report 2026
16 October 2026
NCT04594707 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Emicizumab in Hemophilia A: NCT04621916 Clinical Landscape Report 2026
16 October 2026
NCT04621916 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Saracatinab in Idiopathic Pulmonary Fibrosis: NCT04598919 Clinical Landscape Report 2026
16 October 2026
NCT04598919 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Selvigaltin in Fibrosis, Liver: NCT04607655 Clinical Landscape Report 2026
16 October 2026
NCT04607655 clinical landscape for Fibrosis, Liver: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Recombinant Coagulation Factor VIIa(rEVO Biologics) in Hemophilia A: ACTRN12620001152910 Clinical Landscape Report 2026
16 October 2026
ACTRN12620001152910 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Mitapivat in Anemia, Sickle Cell: NCT04610866 Clinical Landscape Report 2026
16 October 2026
NCT04610866 clinical landscape for Anemia, Sickle Cell: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Insulin (Oramed) in Diabetes Mellitus, Type 2: NCT04616014 Clinical Landscape Report 2026
16 October 2026
NCT04616014 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.